Clinical Considerations Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults
Centers for Disease Control and Prevention. (2021). Clinical Considerations: Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults. U.S. Department of Health and Human Services.
This resource page provides recommendations for clinicians related to reports of myocarditis and pericarditis in adolescents and young adults following mRNA COVID-19 vaccination.
Login to rate, favorite, and comments on the article
You must Login to add a comment
- This item doesn't have any comments